The QualityStocks Daily Friday, August 1st, 2025

Today's Top 3 Investment Newsletters

QualityStocks(EZGO) $0.5100 +51.70%

AINewsWire(BSAI) $12.0000 +50.94%

MarketClub Analysis(TNON) $1.4600 +43.14%

The QualityStocks Daily Stock List

EZGO Technologies (EZGO)

QualityStocks, Premium Stock Alerts, InvestorsUnderground and InvestorPlace reported earlier on EZGO Technologies (EZGO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

EZGO Technologies Ltd. (NASDAQ: EZGO) is a global manufacturer that is engaged in the pro-vision of short-distance transportation solutions. The firm, through its subsidiaries, is engaged in designing, manufacturing, renting and selling e-tricycles and e-bicycles in China.

The firm has its headquarters in Changzhou, the People’s Republic of China and was incorporated in 1954. It became a part of Textron Inc. in 1960. Prior to its name change, the firm was known as EZGO IOT Tech and Services Co. Ltd. It operates in the consumer sector, in the consumer discre-tionary products industry under the automotive sub-industry. The firm serves consumers in China.

The enterprise is focused on developing, operating and maintaining software related to battery rental and e-bicycle services.

The products sold under the company’s brand include the 2Five street-legal low-speed vehicles, Express personality and EZGO Terrain utility vehicles, Freedom TXT and Freedom RXV personal golf cars, and TXT and RXV fleet golf cars. It also provides its smart charging piles under the Hengdian brand; and e-tricycles and e-bicycles under the Cenbird and Dilang brands. This is in addition to producing a line of utility vehicles and heavy duty material carriers, off-road utility ve-hicles for outdoor enthusiasts and hunters and ground support equipment for the aviation industry. Furthermore, the company is also involved in the sale and rental of lithium batteries. It also sells battery cells and packs.

EZGO Technologies (EZGO), closed Friday's trading session at $0.51, up 51.6954%, on 18,379,577 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $0.2856/$1.79.

Clean Energy Technologies (CETY)

QualityStocks, Fortune Stock Alerts, StockRockandRoll, Stock Shock and Awe, SmallCapVoice, Shiznit Stocks, PennyStockLocks.com, PennyPickAlerts, Penny Stock General, Penny Stock Bets, MomentumOTC, Fast Money Alerts and Awareness Stocks reported earlier on Clean Energy Technologies (CETY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Clean Energy Technologies, Inc. (OTCQB: CETY) is focused on designing, producing and mar-keting clean energy products and integrated solutions that are focused on renewable energy and energy efficiency.

The firm has its headquarters in Costa Mesa, California and was incorporated in 1993 by Reza Za-rif and Kambiz Mahdi. Prior to its name change in November 2015, the firm was known as Probe Manufacturing Inc. It operates in the energy sector, under the renewable energy sub-industry and serves consumers in the U.S.

The company operates through the Electronic Assembly and Manufacturing, Cety Europe and Clean Energy HRS segments. The former segment is engaged in the provision of contract manu-facturing services of electronic printed circuit board assemblies to consumers in the aerospace, mili-tary and medical industries while the latter segment is involved in designing, building and deliver-ing power from biomass sources and industrial heating systems to produce energy, through the use of the firm’s Clean Cycle heat generators. On the other hand, its Cety segment handles support, warranty and sales services for the firm’s Clean Cycle brand.

The enterprise’s main product is a generator that captures waste heat from different sources and turns the heat into electricity. The product, which is known as the Clean Cycle generator, is pro-vided by Heat Recovery Solutions. The enterprise’s manufacturing and engineering resources sup-port its heat recovery solutions, as well as other emerging growth firms with its Clean-tech tech-nologies.

Clean Energy Technologies (CETY), closed Friday's trading session at $0.285, up 33.8028%, on 4,876,915 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $0.2012/$1.27.

Evoke Pharma (EVOK)

MarketBeat, QualityStocks, Kiplinger Today, Jason Bond, TradersPro, BUYINS.NET, StockMarketWatch, Marketbeat.com, Daily Trade Alert, StreetInsider, Streetwise Reports, MarketClub Analysis, TopPennyStockMovers, Penny Stock Prodigy, TraderPower, StockEarnings, Investing Futures, InvestorPlace, Barchart, Money Wealth Matters, 360 Wall Street, Seeking Alpha, Trades Of The Day, Short Term Wealth, Stock Market Watch, Street Insider, The Online Investor, The Wealth Report and Schaeffer's reported earlier on Evoke Pharma (EVOK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Evoke Pharma Inc. (NASDAQ: EVOK) (FRA: EV0) is a pharmaceutical firm that is engaged in the manufacture, development and commercialization of therapies that can treat gastroenterological ailments and disorders.

The firm has its headquarters in Solana Beach, California and was incorporated in January 2007 by David A. Gonyer, Scott L. Glenn, Cam L. Garner and Matthew J. D’Onofrio. The firm serves consumers in the United States.

The enterprise markets its products to select health care providers, primary care physicians, internal medicine specialists and gastroenterologists. Its product pipeline is made up of a metoclopramide nasal spray known as Gimoti, which has concluded phase 3 clinical trials testing its effectiveness in treating symptoms linked to recurrent and acute diabetic gastroparesis in females. This gastrointes-tinal disorder hinders the stomach from emptying its contents at the appropriate time, which results in severe digestive system symptoms. It affects millions globally. The spray formulation, which is a mixed 5-HT3 and 5-HT4 antagonist, has anti-emetic and promotility effects and has been designed to offer systemic delivery of the molecule via the nasal mucosa. Before this formulation was devel-oped, metoclopramide was the sole drug available in the U.S. indicated for the treatment of gastro-paresis. The drug was only available in intravenous and oral forms.

Evoke Pharma (EVOK), closed Friday's trading session at $4.6901, up 29.2039%, on 355,372 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $1.94/$12.3199.

Lixte Biotechnology (LIXT)

QualityStocks, TopPennyStockMovers, MarketClub Analysis, PennyStockScholar, StocksEarning, Premium Stock Alerts, Fierce Analyst, HotOTC, INO Market Report, Money Wealth Matters, OTCtipReporter, Penny Pick Finders, PennyStockProphet, Buzz Stocks, PoliticsAndMyPortfolio.com, Wall Street Mover, Profitable Trader Authority, Real Pennies, Small Cap Firm, StockOnion, StockWireNews and PoliticsAndMyPortfolio reported earlier on Lixte Biotechnology (LIXT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT) (FRA: 864) is a drug discovery firm that utilizes biomarker technology to identify enzyme targets associated with severe common ailments and design new compounds to attack these targets.

The firm has its headquarters in East Setauket, New York and was incorporated in 2005, on Au-gust 5th by Robert B. Royds and John S. Kovach. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm has three companies in its corporate family and serves consumers in the United States.

The company is party to a collaboration agreement with Oncode Institute, the Netherlands Can-cer Institute, and the Spanish Sarcoma Group. It is also party to a clinical trial research agreement with the Research Institute Hospital Inc. and the Moffitt Cancer Center.

The enterprise mainly focuses on protein phosphatases inhibitors which can be used solely or in combination with immune checkpoint blockers, x-ray and/or cytotoxic agents. Its products port-folio is comprised of 2 major categories of compounds that are in different stages of clinical and pre-clinical development. The enterprise develops 2 series of pharmacologically active drugs, which include the LB-200 series for the treatment of cancer, neurodegenerative ailments and chronic hereditary illnesses like Gaucher’s disease; and the LB-100 series, which is made up of new structures that may be useful in the treatment of cancers, as well as metabolic and vascular illnesses.

Lixte Biotechnology (LIXT), closed Friday's trading session at $4.87, up 22.67%, on 294,247 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $0.64/$4.88.

Plus Therapeutics (PSTV)

QualityStocks, StockMarketWatch, Premium Stock Alerts, MarketClub Analysis, BUYINS.NET, MarketBeat, Timothy Sykes, The Stock Dork, Schaeffer's, Buzz Stocks, HotOTC, OTCtipReporter, Penny Pick Finders, PennyStockProphet, Profitable Trader Authority, TradersPro, Stock Market Watch, StockEarnings, StockOnion and PennyStockScholar reported earlier on Plus Therapeutics (PSTV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Plus Therapeutics Inc. (NASDAQ: PSTV) (FRA: XMPA) is a clinical-stage pharmaceutical firm that is engaged in developing, manufacturing and commercializing new therapies for patients with cancer, as well as other life-threatening ailments, to address unmet market and medical needs.

The firm has its headquarters in Austin, Texas and was incorporated in July 1996 by Christopher J. Calhoun and Ralph E. Holmes. It serves consumers in the states of California and Texas. Before changing its name in July 2019, the firm was known as Cytori Therapeutics Inc.

The company is party to a license agreement with NanoTx Corp. for the development and com-mercialization of a glioblastoma treatment designed by NanoTx. It provides a nanotechnology plat-form to better and reformulate chemotherapeutics to offer benefits to clinicians and patients. Its candidate drug products are being developed by a team of physicians, engineers, chemists and bi-ologists, among other professionals.

Plus Therapeutics’ product pipeline includes a generic PEGylated liposomal doxorubicin formula-tion called DoxoPLUS which is indicated for the treatment of Kaposi’s sarcoma, multiple myelo-ma, ovarian cancer and breast cancer; a PEGylated liposomal formulation of docetaxel known as DocePLUS indicated for the treatment of solid tumors and small cell lung cancer. The company also develops a patented radiotherapy dubbed Rhenium NanoLiposome, indicated for the treatment of patients with recurrent glioblastoma.

Plus Therapeutics (PSTV), closed Friday's trading session at $0.585, up 21.118%, on 12,423,794 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $0.1634/$2.3099.

Concord Medical Services Holdings (CCM)

SmarTrend Newsletters, MarketBeat, QualityStocks, FutureMoneyTrends.com, BabyBulls, CrushTheStreet.com, StreetInsider, ShazamStocks, The Street, StockMarketWatch, Zacks, Vantage Wire, Marketbeat.com, AllPennyStocks, AnotherWinningTrade, FNNO Newsletters, Market FN, MicroCap Press, TopStockAnalysts, TradersPro, Stock Research Newsletter, Street Insider, Streetwise Reports, The Best Newsletters and MarketClub Analysis reported earlier on Concord Medical Services Holdings (CCM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Concord Medical Services Holdings Ltd. (NYSE: CCM) (FRA: C2CA) manages radiotherapy and diagnostic imaging centers.

The firm has its headquarters in Beijing, the People’s Republic of China and was incorporated in 2007, on November 27th. The firm serves consumers in China.

The company operates through the Hospital and Network segments. It also operates the Beijing Proton Medical Center, which offers radiotherapy treatment options to patients with cancer, as well as other cancer hospitals, which provide surgery, chemotherapy, diagnostic imaging services and radiotherapy services. Its cooperative centers are all equipped with primary medical equipment which includes body gamma knife systems, head gamma knife systems, MRI scanner (magnetic resonance imaging), linear accelerators and PET-CT (positron emission tomography-computer to-mography scanner).

Apart from diagnostic imaging services, the enterprise also provides diagnostic services and treat-ments like tonometry and refraction for diagnosing ophthalmic conditions; stereotactic radiofre-quency ablation for treating Parkinson’s disease; thermotherapy for pain alleviation after chemo-therapy and radiotherapy; and electroencephalography for diagnosing epilepsy. In addition to this, the company also offers clinical support services, which include the development of treatment pro-tocols for physicians. Furthermore, it is also involved in the sale of medical equipment; the provi-sion of tele-consulting services as well as diagnostic and radiotherapy equipment management and leasing services.

Concord Medical Services Holdings (CCM), closed Friday's trading session at $6, up 20.4819%, on 24,239 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $3.8/$10.77.

American BriVision Corporation (ABVC)

QualityStocks, MarketBeat, MarketClub Analysis, AllPennyStocks, Prism MarketView, Profitable Trader Authority, Prism Market View, PennyStockScholar, PennyStockProphet, OTCtipReporter and FreeRealTime reported earlier on American BriVision Corporation (ABVC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American BriVision (Holding) Corporation is a clinical stage biopharmaceutical company listed on the OTCQB. It is developing therapeutic solutions in oncology/hematology, CNS, as well as ophthalmology. The Company has an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development. Founded in 2015, American BriVision has its corporate office in Fremont, California.

The Company centers on using its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process at world-famous research institutions. These include Stanford Uni-versity, University of California at San Francisco, and Cedars-Sinai Medical Center. American BriVision then focuses on out-licensing the products to global pharmaceutical companies for pivotal Phase III studies and, eventually, generating worldwide sales.

American BriVision has its medical device, Vitargus®. In addition, it has its medicine ABV-1505, which is designed to alleviate attention-deficit hyperactivity disorder (ADHD).

Vitargus® is the world’s first biodegradable vitreous substitute used during vitrectomy surgery. The Company states that Vitargus® offers important advantages over present vitreous substitutes by mini-mizing medical complications and lessening the need for additional surgeries.

American BriVision Corporation (ABVC), closed Friday's trading session at $2.75, up 14.5833%, on 320,002 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $0.4/$5.48.

Wellgistics Health (WGRX)

Premium Stock Alerts and MarketClub Analysis reported earlier on Wellgistics Health (WGRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Wellgistics Health Inc. (NASDAQ: WGRX) is a holding company focused on the wholesale and distribution of pharmaceutical products to independent retail pharmacies and pharmaceutical manufacturers.

The firm has its headquarters in Tampa, Florida and was incorporated in 2022, on September 6th by Ajjarapy Surendra. Prior to its name change in October 2024, the firm was known as Danam Health Inc. Wellgistics Health operates as part of pharmaceutical retailers’ industry, under the healthcare sector. The firm primarily serves consumers in the United States.

The company conducts business through its pair of wholly owned subsidiaries; Wood Sage LLC and Wellgistics LLC, as well as 2 indirect subsidiaries, Community Specialty Pharmacy LLC and Alliance Pharma Solutions LLC.

Wellgistics Health focuses on specialty medications and a community-based model offering home delivery services to patients. Its products include Kyzatrex and Semaglutide and Tir-zepatide. The enterprise is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected within the company’s health pharmacy operations. This platform will allow for an end-to-end mobile appli-cation solution whereby patients can digitize their prescription journey. The solution helps to pre-serve patient autonomy, improve prescription price transparency, and provide additional conci-erge services.

The firm recently announced significant Q2 operational results, having added 116 new pharma-ceutical manufacturer partnerships, more than 12,400 new products, and over 275 pharmacies to its national platform. This comes as Wellgistics Health continues to advance toward direct-to-patient care programs and expand its distribution, fulfillment, and pharmacy network, a move that may positively influence investments into the firm.

Wellgistics Health (WGRX), closed Friday's trading session at $0.84, off by 3.2147%, on 298,546 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $0.7514/$7.04.

Hydrograph Clean Power (HGRAF)

We reported earlier on Hydrograph Clean Power (HGRAF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Hydrograph Clean Power Inc. (OTCQB: HGRAF) (CNSX: HG) (FRA: M98) is a development and research firm focused on acquiring and developing graphene and hydrogen-related products and services.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2017 by Harold Charles Davidson. It operates as part of specialty chemicals industry, under the basic materials sector. The firm primarily serves consumers in Canada.

The company’s Hyperion system is modular, scalable and has been proven to use the lowest amount of energy in the industry while producing no waste. Hydrograph Clean Power’s patented technology uniquely positions the company for multiple high growth markets in the production of graphene and other strategic materials.

The enterprise’s principal business activity is the acquisition and development of graphene and hydrogen-related products and services. It produces pristine graphene using an explosion synthe-sis process. Graphene enhances strength, water resistance, flexibility, and electrical conductivity. It boosts clean energy by improving batteries, solar panels, and supercapacitors. Hydrograph Clean Power is also engaged in developing and commercializing a disruptive patented technology for the production of hydrogen and graphene in bulk using detonation of hydrocarbon gases, which does not require external heat sources like conventional production processes. In addition to this, the enterprise is engaged in creating customized graphene solutions for specific applica-tions such as graphene ink for printing electric circuits.

The firm, which recently showcased its Fractal Graphene™ and its proven performance across a wide range of applications including energy storage, coatings, composites, plastics, sensors, and concrete at the 2025 Advanced Materials Show in Birmingham, remains committed to reducing both the environmental and economic costs associated with integrating graphene into advanced materials. This is in addition to generating additional value for its shareholders.

Hydrograph Clean Power (HGRAF), closed Friday's trading session at $0.895, up 7.7664%, on 6,056,559 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $0.0757/$1.29.

Canaan Inc. (CAN)

CryptoCurrencyWire, BillionDollarClub, CurrencyNewsWire, QualityStocks, MarketClub Analysis, Schaeffer's, StockEarnings, InvestorPlace, TradersPro, MarketBeat, StreetInsider, AllPennyStocks, Stockhouse, Dividend Report, Energy and Capital, INO Market Report, Investment Insights Report, Investors Alley, The Online Investor, Acorn Wealth, Wealth Daily, The Street, SmarTrend Newsletters, Early Bird, Stock Fortune Teller, TopStockAnalysts, StockMarketWatch, BUYINS.NET, Trades Of The Day, StocksEarning and InvestorsUnderground reported earlier on Canaan Inc. (CAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Argentina is stepping up its efforts to stop the use of crypto in the financing of terrorism. The country’s Financial Information Unit (UIF) recently uncovered possible links between local crypto platforms and the Syrian militant group Hay’et Tahrir Al-Sham (HTS), known for its connections to Al Qaeda.

The UIF oversees counter-terrorism funding and anti-money laundering activities in Argentina. The regulator collaborated with blockchain analysts over a six-month period to dig into these activities. Using advanced blockchain tracing software, the experts traced the movement of digital assets across multiple wallets.

Their findings revealed connections to ransom payments and financial transfers possibly directed toward regions affected by war. Some of the funds also appeared to pass through dark web networks.

According to officials, two individuals are under scrutiny. One is a Russian citizen living in Argentina. The other, whose identity was flagged by both the U.S. Treasury Department and Israel’s National Bureau for Counter Terror Financing (NBCTF), is also believed to be a foreign national. Authorities suspect they may be working together in support of HTS.

Although the United States recently removed HTS from its official list of Foreign Terrorist Organizations (FTOs), many international law enforcement bodies still regard it as a terrorist threat.

The UIF stated that there’s no evidence suggesting an immediate threat to Argentina itself. However, under international obligations, specifically those set by the Financial Action Task Force (FATF), the country is required to respond when there are signs of terrorist financing linked to global threats.

The UIF acted on tips from both a local and a foreign source. A federal judge approved the UIF’s request to freeze the crypto assets in question. Local authorities explained that this was just the first move in a broader investigation. The initial step involved blocking access to all associated wallets and stopping any attempts to move funds.

Insiders also mentioned that some of the wallet addresses involved might be linked to other illegal groups, though details on those connections remain undisclosed at this time.

This operation is part of the country’s broader effort to strengthen its anti-money laundering regulations, which were updated in 2023. As part of those reforms, digital currency exchanges are now under tighter surveillance, especially when transactions involve users flagged as high-risk, such as certain nonprofits or politically exposed individuals. Since the implementation of new measures, reports of suspicious transactions have reportedly dropped by 30%.

Major crypto players like Canaan Inc. (NASDAQ: CAN) are unlikely to see any problem with these enforcement actions since they help to weed out bad actors that could give the industry bad press and hinder the inroads being made to take crypto mainstream around the world.

Canaan Inc. (CAN), closed Friday's trading session at $0.6591, off by 4.5336%, on 49,498,348 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $0.5347/$3.27.

SKYX Platforms (SKYX)

TechMediaWire, QualityStocks, PCG Advisory, MarketBeat, InvestorPlace and Prism MarketView reported earlier on SKYX Platforms (SKYX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SKYX Platforms (NASDAQ: SKYX) , a smart home platform technology company with more than 97 issued and pending patents globally and a portfolio of over 60 lighting and home décor websites, announced record pre-audited revenues of $23.1 million for the second quarter ended June 30, 2025, up from $20.1 million in the first quarter. The Company has delivered six consecutive quarters of revenue growth, with results rising from $19 million in Q1 2024 to $23.1 million in Q2 2025. Rani Kohen, Founder/Inventor and Executive Chairman, said the record performance underscores SKYX’s ability to expand its retail and pro channels, leverage its e-commerce platform and advance its smart home technologies while driving recurring revenue opportunities.

To view the full press release, visit https://ibn.fm/MWbpk

About SKYX Platforms Corp.

As electricity is a standard in every home and building, our mission is to make homes and buildings become safe-advanced and smart as the new standard. SKYX has a series of highly disruptive advanced-safe-smart platform technologies, with over 97 U.S. and global patents and patent pending applications. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at https://skyplug.com/ or follow us on LinkedIn .

SKYX Platforms (SKYX), closed Friday's trading session at $1, even for the day, on 747,575 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $0.8001/$2.135.

Trulieve Cannabis Corp. (TCNNF)

CannabisNewsWire, QualityStocks, InvestorPlace, MarketBeat, Wealth Insider Alert, Daily Trade Alert, Cabot Wealth, Top Pros' Top Picks, The Street, Trades Of The Day, Profit Trends, TradersPro, The Online Investor, StreetInsider and Prism MarketView reported earlier on Trulieve Cannabis Corp. (TCNNF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Discussions on recreational cannabis legalization are gaining momentum in Pennsylvania after a key GOP state senator introduced a bill on the matter. 

The measure, introduced by Senators Sharif Street and Dan Laughlin, would legalize recreational marijuana for adults aged 21 and older. It also opens the door for current medical cannabis operators to expand into the recreational market, provided they pay a $100,000 transition fee. 

One of the main points of contention is how easily existing medical dispensaries should be allowed to switch to recreational sales. Critics, particularly those advocating for small businesses, argue that the $100,000 fee is too low and could lead to larger players gaining an unfair advantage. 

To address equity concerns, the bill sets a $50,000 application fee for small businesses and applicants from disproportionately impacted communities. Each group would be capped at 15 licenses. 

Senator Laughlin, who chairs the Senate’s Law and Justice Committee, holds a key position in determining the future of marijuana legislation. Earlier this year, he blocked a House-backed measure that would have introduced state-run cannabis stores, modeled after Pennsylvania’s state-run liquor stores. 

Key GOP leaders in the Senate have already expressed little interest in advancing recreational marijuana bills. Joe Pittman, the Senate Majority Leader, for instance, said there’s no broad support for legalization within their caucus. Senate Appropriations Committee chair, Senator Scott Martin, has also declined to consider such legislation, which further dims its chances. 

Even members of Laughlin’s committee have voiced concerns, citing potential public health and safety risks. 

Over in the House, Democrats are pushing their own bills. Representative Amen Brown introduced a version of the Senate proposal, maintaining the same structure and language. Meanwhile, a different proposal by Representatives Abby Major and Emily Kinkead creates a regulatory board, permits medical operators to transition to recreational sales, and includes a $100,000 conversion fee. 

Their bill adds labor representation on the board and reserves more licenses for social equity applicants, small businesses, and micro-growers. Application fees for these groups would be determined later by the board. 

Representative Rick Krajewski, who supported the state-run model, remains skeptical. He doubts any of the current measures will move forward, given the Senate GOP’s opposition. For him to support a private-market model, he says it would need to include strong safeguards for small operators, such as guaranteed early access to customers, to level the playing field. 

These discussions to determine how best to legalize adult-use marijuana in the state while avoiding giving existing industry players an unfair advantage is similar to the discussions over in Florida where medical marijuana entities like Trulieve Cannabis Corp. (CNX: TRUL) (OTCQX: TCNNF) have been working to pass a legalization measure for recreational marijuana. 

Trulieve Cannabis Corp. (TCNNF), closed Friday's trading session at $4.7, up 8.046%, on 644,734 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $3.02/$13.78.

The QualityStocks Company Corner

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)

The QualityStocks Daily Newsletter would like to spotlight ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).

Canadian-based ESGold is preparing to begin a tailings cleanup and reuse operation at its Montauban historic mine site holdings, with plans to generate revenues that can eventually be invested in new exploration at the site without dependence on market funding

ESGold recently announced the results of a non-invasive Ambient Noise Tomography (ANT) survey at the site, which identified several significant genetic and structural similarities with the globally renowned Broken Hill deposit in New South Wales, Australia

The analogues between Montauban and Broken Hill strengthen ESGold's theory that exploration potential remains open at depth both vertically and laterally for a polymetallic deposit, reinforcing the company's evolving view of Montauban as a structurally complex, vertically continuous mineral system

The near-term tailings reuse cash flow strategy is expected to generate $350 million during the first few years of operation

Sustainable gold mining innovator ESGold (CSE: ESAU) (OTCQB: ESAUF) is reporting the excitement over findings that its Montauban recovery site in Quebec, Canada, shows significant similarities with a globally renowned metal deposit in Australia — shifting Montauban from classification as a simple historic producer to a high-impact exploration opportunity.

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is a fully permitted, pre-production resource company on a clear path to near-term gold and silver production. With established infrastructure in place and a significant gold-silver resource, the company is uniquely positioned to generate near-term cash flow while unlocking the full potential of its Montauban Gold-Silver Project in Quebec—one of the top mining jurisdictions in the world.

ESGold is building a foundation for long-term growth through a dual-track strategy: cash-flow generation from tailings reprocessing to fund district-scale exploration.

The Montauban site, which operated as a mine for over 80 years, is now undergoing its first-ever systematic exploration program to determine just how large the remaining deposit may be. Near-term cash flow from tailings reprocessing will be used to fund exploration, with the goal of increasing the resource base and uncovering new discoveries across the expansive land package.

ESGold is advancing a scalable and replicable clean extraction model that turns legacy mine sites into revenue generating assets while setting a new industry benchmark for sustainable resource recovery.

The recent completion of a C$3.4M financing has enabled ESGold to initiate the final construction phase of its mill circuit—moving the company decisively toward production of gold and silver in Q3 2025.

Montauban Gold-Silver Project: Production Imminent

Located approximately 80 kilometers west of Quebec City, the Montauban Project is a past-producing gold-silver mine with surface and underground mineralization and over 900,000 tonnes of historical tailings. ESGold has invested over C$15 million to date, building out roads, power access, and a 16,000 sq. ft. processing facility. The company recently completed a C$3.4M financing to begin final construction of the mill circuit.

The company is fully permitted to enter into production that is expected to commence in Q3 2025 with a capacity of 500 tonnes per day, scaling to 1,000 tpd. An updated Preliminary Economic Assessment (PEA) is currently underway to reflect all-time high gold prices and the anticipated upside from the near-surface resource.

Parallels Between Broken Hill & Montauban

Broken Hill, discovered in 1883 in Australia, became the world’s largest source of silver, lead, and zinc—producing over $100 billion worth of metals. What made it unique was that the richest mineral zones were hidden deep underground in a twisted, boomerang-like shape, and it took decades to fully understand just how large the deposit really was.

Geologists now believe ESGold’s Montauban Project in Quebec may share similar traits. Like Broken Hill, it contains high-grade silver, lead, and zinc, along with gold—and sits within the same type of geological system known to host large, high-value mineral deposits. The rock formations, mineral assemblages, and structural complexity all suggest that Montauban could be hiding much more than what’s been historically uncovered. Academic studies now support this possible geological parallel, pointing to further evidence suggesting Montauban was formed under similar conditions as Broken Hill.

Exploration Upside

With production on the horizon, ESGold is advancing a major exploration campaign. Montauban has never undergone systematic modern exploration.

The company is currently completing a large-scale Ambient Noise Tomography (ANT) survey—a powerful 3D imaging technology that will define the size, shape, and continuity of the mineralized system. ANT is already showing strong results, with imaging going beyond the original 400m depth target and now expected to exceed 800m. This cutting-edge technology has the potential to reveal the full extent of the anomaly for the first time in Montauban’s 110-year history.

Scalable, Replicable, Clean Mining

Montauban is also part of a broader vision. Across Canada and globally, there are hundreds of orphaned or legacy mine sites that remain unrehabilitated despite containing valuable residual metals in tailings. Quebec alone is home to more than 259 of these sites, highlighting the scale of the opportunity. ESGold is advancing a scalable and replicable clean extraction model that transforms legacy sites into productive assets while setting a new benchmark for sustainable resource recovery.

The company has also performed testing that utilizes Dundee Sustainable Technologies’ CLEVR Process™, a proprietary non-cyanide extraction method that achieved 90.9% gold recovery in lab testing. This clean processing approach remains a valuable and scalable asset supporting ESGold’s near-term production and exploration growth strategy.

As a complement to its core mining operations, ESGold is developing clean technology solutions through a joint venture with DMCMS Inc. This initiative includes a polymer division that manufactures environmentally friendly products such as road stabilizers, dust suppressants, and other industrial blends—expanding the company’s sustainable commercial footprint.

Market Opportunity

ESGold is operating in a unique and specialized segment of the mining industry—reprocessing and revitalizing legacy mine sites. The Montauban Project offers both near-term cash flow and long-term growth potential by converting tailings into revenue while systematically exploring for additional high-value mineral endowments. The company’s established infrastructure, full permitting, and reclamation approvals reduce development risk and enhance execution timelines.

The broader green mining market is projected to reach $15.92 billion by 2030, according to Grand View Research. This growth is being driven by increased demand for responsible extraction methods, ESG-aligned practices, and critical mineral security. With construction underway at its fully permitted Montauban site—and exploration advancing along a Broken Hill-type geological model—ESGold is well positioned to emerge as Canada’s next premier gold and silver producer.

Leadership Team

Paul Mastantuono, Chief Executive Officer and Director, graduated with distinction from the University of Ottawa with a bachelor’s degree in social science, concentrating in criminology. He has extensive experience in the construction and transportation industries and has worked as an independent business consultant for various companies, including DNA Precious Metals Inc.

Brad Kitchen, President and Director, brings over 35 years of experience in investment banking and senior corporate management, primarily with resource-based companies. He has a detailed knowledge of regulatory, security, and tax issues, cross-border financings, and market influences, which he has applied to address business challenges for issuers and investors. Mr. Kitchen was also CEO of Eagle Hill Exploration, the company that generated in only five years the first Bankable Feasibility Study on the Windfall Lake Gold Project that was recently sold by Osisko Mining to Gold Fields for US$1.6 billion.

Andre Gautier, Senior Geologist and Director, brings over 47 years of experience in the Mining Exploration field and has worked in over 35 countries. His work experience includes entities such as: SOQUEM, Falconbridge Ltd., Noramco and Cambior Inc. Mr. Gauthier was president of MaxyGold Corp. (China), INCA Pacific Resources Inc., Lara Exploration Ltd., and Gold Holding Ltd. Mr. Gauthier also served as a Director of Vena Resources Inc., MaxyGold Corp., Lara Exploration Ltd., Western Union Peru, and Gold Holding Ltd., and from March 2015 until 2018, he served as interim Managing Director and CEO of Gold Holding Ltd., headquartered in Dubai (UAE). He has a BSC in Geology Eng. and MSC from UQAC (Chicoutimi, Quebec) and is an active member and leader of many mining and professional organizations (Canada, Peru, UAE, and China).

Investment Considerations
  • Fully Permitted & Funded for Near-Term Production: Construction underway soon at Montauban with gold-silver production expected in Q3 2025.
  • Tailings-to-Cashflow Strategy: Near-term cash flow from processing historic tailings will fund exploration across the district-scale land package.
  • Replicable Clean Mining Model: Scalable approach to legacy mine redevelopment in Canada and globally.
  • Broken Hill Analogue: Geological and structural parallels suggest Montauban may host a larger, mineralized system at depth.
  • Modern 3D Imaging Tech: Cutting-edge ANT survey is producing subsurface imaging beyond 800m, uncovering the potential size of the deposit.

ESGold Corp. (OTCQB: ESAUF), closed Friday's trading session at $0.6649, up 7.2419%, on 68,195 volume. The average volume for the last 3 months is 252,060 and the stock's 52-week low/high is $0.0221/$1.1.

Recent News

Nightfood Holdings Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (OTCQB: NGTF).

Nightfood Holdings (OTCQB: NGTF) , a company integrating AI-driven automation with strategic hotel asset ownership, announced it is finalizing due diligence and moving toward definitive agreements to acquire two flagship hotel properties in Victorville and Rancho Mirage, California. The combined $80 million in institutional-grade assets will serve as a cornerstone of Nightfood's vertically integrated hospitality and Robotics-as-a-Service model. CEO Jimmy Chan said the acquisitions will embed next-generation automation directly into hotel operations, creating scalable recurring revenue while addressing labor challenges. The company expects to close both transactions before the end of the current quarter, integrating the properties into its AI automation platform to drive efficiency, guest satisfaction and long-term growth.

To view the full press release, visit https://ibn.fm/K3qNa

Nightfood Holdings Inc. (OTCQB: NGTF) is a hospitality technology and asset acquisition company revolutionizing hotel operations through AI-driven service robotics and strategic property acquisitions. By integrating advanced automation solutions with high-value hospitality assets, NGTF is setting a new standard for operational efficiency, cost reduction, and labor optimization in the hospitality industry.

With a focus on Robotics-as-a-Service (RaaS) and hotel ownership, NGTF is uniquely positioned at the intersection of technology and real estate, creating scalable, revenue-generating solutions that drive the widespread adoption of automation in the hospitality sector.

Operations

Nightfood Holdings is focused on two core business areas:

  • Hotel Acquisitions & Operations – NGTF is acquiring a portfolio of independent hospitality properties, spanning various market segments from midscale to luxury. These hotels serve as real-world testbeds for automation technologies, allowing NGTF to refine its RaaS solutions before deploying them at scale.
  • Robotics-as-a-Service (RaaS) for Hospitality – NGTF provides subscription-based, AI-driven robotic automation, designed to optimize hotel operations. By deploying standardized automation solutions, NGTF helps hotels reduce costs, improve labor efficiency, and enhance guest experiences.

Through this fully integrated model, NGTF ensures that its robotics solutions are tested, optimized, and proven profitable before expanding to third-party hotel operators.

Market Opportunity

The demand for automation in hospitality is accelerating, driven by labor shortages, rising costs, and increased competition. NGTF is positioned to capitalize on this shift through its combined hotel ownership and RaaS strategy.

  • Total Addressable Market (TAM): The global service robotics market is projected to reach approximately $107.75 billion by 2030, driven by widespread adoption across industries including hospitality, according to Research and Markets.
  • Serviceable Available Market (SAM): The global smart hospitality market, which includes AI and automation technologies for hotels, is projected to reach $186.10 billion by 2032, according to SNS Insider.
  • Competitive Positioning: NGTF’s unique real estate + automation model allows it to implement cost-saving robotics solutions in real-world environments before expanding adoption across the industry.

Industry Impact: The Future of Smart Hotels

NGTF is at the forefront of next-generation hospitality automation, transforming how hotels operate. By combining AI-powered service robotics with real estate acquisitions, NGTF is pioneering the transition to smart, highly efficient hotel environments.

Hotels acquired by NGTF serve as testing grounds for robotics deployment, allowing the company to continuously refine its automation solutions. The biggest industry benefits include:

  • Cost Savings for Hotel Operators – Reducing labor costs and improving operational efficiency.
  • Scalability & Standardization – Offering a streamlined, subscription-based RaaS model for seamless automation adoption.
  • Industry Leadership in Hotel Robotics – Driving the transformation of hospitality with AI-powered automation solutions.

Future Vision & Growth Strategy

Over the next three to five years, NGTF is committed to scaling both its hotel portfolio and RaaS adoption. By refining and optimizing its automation technologies in its own properties, NGTF will continue deploying RaaS to third-party hotel operators, positioning itself as a leader in next-generation hospitality automation.

Through strategic acquisitions and AI-driven solutions, NGTF is defining the future of smart hotels—delivering cost-efficient, scalable automation that reshapes the hospitality landscape.

Team Expertise as a Strategic Advantage

In addition to technology and real estate, NGTF’s most powerful asset is its team. The company’s leadership and operating partners bring deep expertise in both hospitality and food service, having collectively developed over 50 properties, managed more than 130 hotels, and supported more than 6,000 quick-service restaurants.

This wealth of experience enables NGTF to execute its automation and acquisition strategy with operational discipline, industry insight, and scale—further strengthening its position in next-generation hospitality.

Investment Considerations
  • Dual Growth Strategy – NGTF combines hotel acquisitions with AI-powered automation, creating an integrated model that maximizes operational efficiency and revenue potential.
  • Expanding Robotics-as-a-Service (RaaS) – Subscription-based robotic automation solutions designed to reduce operational costs and address labor shortages for hotel operators.
  • Strategic Hotel Acquisitions – Acquiring a variety of hospitality assets, from midscale to luxury, to serve as testing grounds for AI-driven automation and to drive profitability.
  • Proven Market Demand – Rising labor costs and increasing adoption of service robotics are fueling demand for automation in hospitality, positioning NGTF as an early leader in the sector.
  • Scalable & Revenue-Generating Model – By owning hotels and offering RaaS to third-party operators, NGTF is building a diversified, high-growth business model.

Nightfood Holdings Inc. (OTCQB: NGTF), closed Friday's trading session at $0.02, up 60%, on 2,289,207 volume. The average volume for the last 3 months is 562,310 and the stock's 52-week low/high is $0.0053/$0.0571.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

Samsung has signed a major $16.5 billion deal to produce AI chips for Tesla. Although Samsung didn't mention Tesla by name in its official filing, Elon Musk confirmed the news on his platform, X. According to Musk, Samsung will manufacture Tesla's upcoming AI6 chips at a newly built facility in Texas. He underscored the significance of the agreement, calling it a critical step forward for both companies. "This is a major milestone," Musk noted in his post. Currently, Samsung is responsible for producing Tesla's AI4 chips, which are used in its self-driving systems. Meanwhile, Taiwan's TSMC is set to manufacture the AI5 chips, with production starting in Taiwan and eventually shifting to Arizona, according to Musk. Samsung's shares jumped 6.8%, while Tesla's saw a 4.2% gain following the announcement. Such deals pave the way for other tech firms like D-Wave Quantum Inc. (NYSE: QBTS) to take a leaf and nurture similar collaborations in order to deepen their market penetration. 

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Friday's trading session at $16.38, off by 4.712%, on 31,626,288 volume. The average volume for the last 3 months is 45,843,697 and the stock's 52-week low/high is $0.7505/$20.56.

Recent News

Bollinger Innovations, Inc. (NASDAQ: BINI)

The QualityStocks Daily Newsletter would like to spotlight Bollinger Innovations, Inc. (NASDAQ: BINI).

BYD has become the first player in the global new energy vehicle (NEV) sector to produce 13 million NEVs. The Chinese automaker manufactured its 13th million NEV on July 21st, reaching a milestone that even Tesla, the most dominant electric vehicle manufacturer in the world, has yet to reach. The milestone is a significant achievement for both BYD, which has faced numerous challenges in recent years, and the development of the global new energy vehicle segment, an admittedly small but fast-growing industry. As demand for clean transportation continues to surge, BYD's rapid growth signals a larger shift in global mobility. With strong international expansion, investment in battery innovation, and a strategy that caters to a wider market than Tesla, BYD is positioned to shape the next phase of the EV revolution. Its multi-pronged approach could help accelerate the end of fossil fuel reliance and bring sustainable transport to the mainstream. Entities like Bollinger Innovations, Inc. (NASDAQ: BINI) could draw some lessons from the rise of BYD and know that it is just a matter of time before they too establish a global presence if they stay focused on executing their growth strategy. 

Bollinger Innovations, Inc. (NASDAQ: BINI) is a Southern California-based automotive company building the next generation of commercial electric vehicles (“EVs”) with United States-based manufacturing located in Tunica, Mississippi.

In August 2023, Mullen began commercial vehicle production in Tunica. As of January 2024, both the Mullen ONE, a Class 1 EV cargo van, and Mullen THREE, a Class 3 EV cab chassis truck, are California Air Resource Board (“CARB”) and EPA certified and available for sale in the U.S. The Company’s commercial dealer network consists of Papé Kenworth, Pritchard EV, National Auto Fleet Group, Ziegler Truck Group, Range Truck Group, Eco Auto, and Randy Marion Auto Group, providing sales and service coverage in key West Coast, Midwest, Pacific Northwest, New England, and Mid-Atlantic markets.

In September 2022, Bollinger Motors, of Oak Park, Michigan, became a majority-owned EV truck company of Mullen Automotive. Bollinger Motors has passed numerous milestones including its B4, Class 4 electric truck production launch on Sept. 16, 2024, and the development of a world-class dealer network with over 50 locations across the United States for sales and service support.

Mullen Commercial

Mullen is defining a new era in commercial vehicles with its connected and customized solutions aimed at making businesses more efficient and profitable.

Mullen ONE Class 1 EV Cargo Van

The Mullen ONE class 1 commercial electric vehicle is the first of its kind in the U.S. market. This van was designed to navigate within narrow urban streets and residential roads, all while maximizing payload and cargo space. The Mullen ONE’s height is less than 6.5 feet, meaning your driver can park the vehicle in a residential garage.

Mullen THREE Class 3 Electric Truck

The efficient urban utility low cab forward features a tight turning diameter of 38 feet and excellent visibility for superior maneuverability on narrow city streets. Even in reverse, maneuverability is a breeze with our standard backup camera and 7-inch display screen. This versatile chassis provides a clean top-of-rail for easy upfitting with bodies up to 14 feet long and over 5,300 lbs of payload. In addition, the design of the LCF chassis allows more cargo length within a given overall length.

Mullen Commercial EVs are eligible for several federal and state level EV incentives, which can be combined for maximized savings.

Mullen ONE:

  • $7,500 Federal Tax Credit
  • $3,500 MOR-EV Incentive (Massachusetts only)
  • $7,500 ComEd Business & Public Sector EV Rebate Program (Illinois only)

Mullen THREE:

  • $7,500 Federal Tax Credit
  • $45,000 California’s Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project (HVIP) (California only)
  • $15,000 MOR-EV Incentive (Massachusetts only)
  • $30,000 ComEd Business & Public Sector EV Rebate Program (Illinois only)

In the last two years, Mullen has conducted over 100 vehicle demos or pilots across various industries in the U.S. resulting in significant progress, including new sales opportunities and vehicle orders received and or completed:

  • Universities: Princeton University, University of Virginia (UVA), University of California, Los Angeles (UCLA)
  • Local city governments: Cities of Dublin, Ohio, Raleigh, North Carolina, Los Angeles, California, Seattle, Washington and Orange County, North Carolina
  • Small businesses: From local florist shops to health care providers delivering supplies

Mullen has an extensive dealer network in the U.S. with renowned dealers nationwide including:

  • Papé Group (California, Oregon, Washington)
  • National Auto Fleet Group (California)
  • Pritchard EV (Iowa)
  • Eco Auto (Massachusetts)
  • Ziegler Truck Group (Minnesota)
  • Range Truck Group (Washington)
  • Mullen Commercial Vehicle Center (California)

Mullen Commercial EVs are available for purchase on Sourcewell under NAFG’s Sourcewell Contract # 091521-NAF which offers Class 1-3 light duty trucks, cars, vans, SUVs, cab chassis, and electric vehicles with related equipment and accessories to U.S. government agencies.

Bollinger Motors

Mullen entered the medium-duty truck classes through its September 2022 acquisition of a controlling interest in EV truck innovator Bollinger Motors. The acquisition gave Mullen access to a significant pipeline of interest from large companies for commercial electric truck classes 3-6 in a wide range of markets, such as last-mile delivery, refrigeration, utilities and upfitters.

The 2025 Bollinger B4 chassis cab is an all-new, all-electric Class 4 commercial truck designed from the ground up with extensive fleet and upfitter input. Bollinger’s unique chassis design protects the 158-kWh battery pack and components to offer unparalleled capability and safety in the commercial market. The vehicle also features a payload in excess of 7,300 pounds with an average driving range of 185 miles. Bollinger Motors began serial production of the B4 on Sept. 16 via its manufacturing partnership with Roush Industries at their facility in Livonia, Michigan.

Bollinger Motors has passed numerous milestones in recent months, including:

  • 30 B4s delivered and paid for, worth nearly $4.5 million, since start of production
  • Its production launch on Sept. 16 at Roush Industries in Livonia, Michigan
  • Achieving FMVSS compliance
  • Receiving the Certificate of Conformity from the Environmental Protection Agency, and CARB certification
  • The creation of a world-class dealer and service network
  • An agreement with Our Next Energy in Novi, Michigan, for battery packs
  • Providing a full warranty coverage of the B4 chassis cab
  • Announcing Syncron as its warranty administration partner and Amerit Fleet Solutions as its mobile service provider
  • A partnership with EO to power EV charging infrastructure, equipment and technology solutions for Bollinger’s dealers and customers

Bollinger Motors has qualified for multiple federal and state incentive programs, including:

  • Inflation Reduction Act incentives of up to $40,000 per vehicle
  • California: Innovative Small e-Fleet (ISEF) Pilot Program, with incentives up to $120,000 per vehicle
  • Massachusetts: voucher of up to $30,000 per vehicle from Massachusetts Offers Rebates for Electric Vehicles (MOR-EV)
  • New York: up to $100,000 from NYTVIP through NYSERDA
  • Pennsylvania: up to a $20,000 grant from Alternative Fuels Incentive Grant Program (AFIG) of the Pennsylvania Department of Environmental Protection

Mullen FIVE RS

The Mullen FIVE RS is an ultra-high-performance EV Crossover featuring a top speed of over 200 mph and acceleration from 0-60 mph in under 2 seconds. The FIVE RS is equipped with 800-volt architecture, all-wheel drive, two-speed gearbox, and over 1,100 horsepower.

The Mullen FIVE RS is planned for launch in Germany with vehicle sales planned for December 2025. Initial vehicle market territories include the EU in 2025, followed by the UAE and South Africa in early 2026.

Mullen is partnering with Faissner Petermeier Fahrzeugtechnik AG (“FPF”), which has decades of experience in the development and production of serial components and sophisticated vehicles for global brands such as Piech Automotive, Gumpert Automotive and is in partnership with BMW of all the above. FPF is certified according to the IATF standard and fulfills all the special requirements of the Federal Motor Transport Authority in Germany.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

Mullen is led by an executive team with extensive EV, OEM and high-growth startup experience.

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working towards a sustainable future by creating a suite of clean-energy, electric vehicles at varied price points. With entirely US based manufacturing and operations, Mr. Michery is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Investment Considerations
  • Mullen Automotive is working diligently to provide exciting commercial EV options assembled in the United States and made to fit perfectly into the American commercial operations
  • Mullen Automotive owns its U.S. manufacturing and assembly facility in Tunica, MS (commercial vehicles)
  • In September 2022, Bollinger Motors, Inc. became a majority-owned EV truck company of Mullen. Bollinger has passed numerous milestones, including its B4, Class 4 electric truck production launch on Sept. 16, 2024, and the development of a world-class dealer and service network with over 50 locations across the United States
  • Mullen currently has three commercial EVs in the market including the Mullen ONE Class 1 EV cargo van, the Mullen THREE Class 3 electric truck, and the Bollinger B4 Class 4 electric truck
  • The Mullen FIVE RS, an ultra-high-performance FIVE RS EV Crossover features a top speed of over 200 mph and acceleration from 0-60 mph in under 2 seconds, is gearing up for launch in Germany in December 2025
  • Mullen is working to actively develop the next-generation solid-state polymer (SSP) batteries and to transition to American-made battery components
  • The global EV market is forecast to grow at a CAGR of 22.6% through 2027.
  • Mullen is led by CEO and Founder David Michery, a seasoned executive with more than 25 years of management, marketing, distressed assets and business restructuring experience

Bollinger Innovations, Inc. (NASDAQ: BINI), closed Friday's trading session at $0.0347, off by 15.7767%, on 150,390,349 volume. The average volume for the last 3 months is 114,513,838 and the stock's 52-week low/high is $0.0311/$58200000.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

Researchers at the University of Kentucky have identified a key genetic biomarker that treatment teams could rely on to predict which patients having glioblastoma stand higher chances of benefiting from bevacizumab, a cancer drug. The study, whose findings were published in the journal JCO Precision Oncology, found that patients who had a genetic alteration referred to as CDK4 and were treated using bevacizumab tended to have longer survival times when compared to patients that underwent the same treatment but didn't have this genetic change. The analysis revealed the specific genetic alteration that increased the odds of beneficial treatment with this particular drug. No other study of this scale had been undertaken before with a focus on identifying molecular biomarkers associated with prolonged beneficial use of this medication. This research marks another step forward in understanding how cancer treatment works in relation to factors within individual patients. As more treatment options for brain cancers like GBM are developed by firms like CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a time may come when every patient has a treatment option that can be beneficial to them. 

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (https://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Friday's trading session at $7.7, off by 3.5088%, on 15,926 volume. The average volume for the last 3 months is 27,159 and the stock's 52-week low/high is $7.5/$221.94.

Recent News

PowerBank Corporation (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN)

The QualityStocks Daily Newsletter would like to spotlight PowerBank Corporation (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN).

SolarBank Corporation has changed its name to PowerBank Corporation to better align with its expanding clean energy portfolio.

PowerBank develops solar and battery storage projects in the U.S. and Canada.

The firm holds a project pipeline exceeding one gigawatt and a built project base of 100 MW.

A recently announced $100 million financing with CIM Group is set to accelerate U.S. project construction.

U.S. tax incentives and Canadian contract programs position the company for stable growth and investor appeal.

Disseminated on behalf of PowerBank Corporation

SolarBank Corporation, a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., is now PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) , a move that underscores the company's evolving business model and its role in powering the digital economy. The name change, effective July 28, 2025, was approved by shareholders and reflects a strategic shift from a solar-centric identity toward a broader energy infrastructure platform ( https://ibn.fm/CDCjI ).

Several countries worldwide are increasingly incorporating biogas into their energy mixes as a replacement for fossil fuels. European nations such as Italy, France, Germany, Denmark, and the United Kingdom are making biogas, a gaseous renewable energy typically produced from agricultural materials, a key part of their energy strategies as they work to reduce their reliance on fossil fuels and meet decarbonization goals. Also referred to as renewable natural gas (RNG), biogas is also gaining popularity in the United States and Canada thanks to capital investments from large gas utilities and transportation-related credits. In some regions, it is even being used as a long-term energy source. Europe is leading the way, with France emerging as one of the biggest adopters thanks to regional planning, grid injection mandates, and a supportive feed-in tariff system. The world needs many alternatives to fossil fuel, and biogas is one such option. Commercial and residential users that can leverage it should do so, while others for whom other renewable energy solutions from companies like PowerBank Corporation (NASDAQ: SUUN) Cboe CA: SUNN) (FSE: GY2) are suitable can also use them.

PowerBank Corporation (NASDAQ: SUUN) (CSE: SUNN) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the United States. The company is committed to advancing the transition to sustainable energy by offering end-to-end services that include project origination, financing structuring, engineering, procurement, construction, and long-term operations and maintenance. PowerBank focuses on delivering innovative energy solutions through solar photovoltaic systems, battery energy storage systems (BESS), and electric vehicle (EV) charging infrastructure.

With a vision to provide scalable and reliable clean energy solutions, PowerBank has established itself as a leader in the renewable energy market by cultivating partnerships with utilities, commercial and industrial entities, municipalities, and residential customers. Its vertically integrated business model allows for optimized efficiency, cost management, and returns across diverse markets in North America. This end-to-end approach ensures greater control over project quality, costs, and operational outcomes, strengthening its competitive position.

Driven by a mission to create a greener future, PowerBank manages a robust portfolio of projects, including more than 100 megawatts (MW) of developed capacity and a pipeline exceeding one gigawatt (GW). The company’s commitment to sustainability and innovation makes it a recognized player in the renewable energy sector.

PowerBank has offices in Toronto, Ontario and New York.

Projects

PowerBank boasts an impressive and diverse portfolio of renewable energy initiatives that underline its leadership in the clean energy space. In the U.S., the company has over 250 MW of solar projects under development, principally in New York, focusing on community solar farms and commercial and industrial installations. Notably, PowerBank is developing several community solar projects in upstate New York, which will deliver clean energy to local residents and small businesses. Community solar projects, which are a cornerstone of PowerBank’s portfolio, provide scalable solutions for renters, homeowners, and small businesses to access affordable renewable energy, driving localized energy independence and economic savings.

In Canada, PowerBank has been a significant participant in Ontario’s Feed-in-Tariff program, where it has secured contracts for close to 200 MW of capacity. Its current management includes 70 solar power projects, totaling 28.8 MW of operational solar assets. The company’s expertise extends to the development and ownership of battery energy storage systems and EV charging stations, further diversifying its portfolio.

The company’s vertically integrated approach spans the entire project lifecycle, from initial site acquisition and grid interconnection to long-term operation and maintenance services. This ensures seamless execution and high-quality outcomes, providing value to stakeholders and supporting the transition to a clean energy future.

Market Opportunity

PowerBank operates within a growing renewable energy market driven by global demand for sustainable power solutions. In North America, favorable policies such as the Inflation Reduction Act in the United States and Canada’s investments in green technologies provide a robust foundation for renewable energy adoption. Solar PV installations and battery energy storage systems are at the forefront of this expansion, addressing energy reliability and grid stability while reducing carbon emissions.

The North American solar PV market was valued at $25.02 billion in 2019 and is projected to reach $120.74 billion by 2027, growing at a compound annual growth rate (CAGR) of 21.7% from 2020 to 2027. Likewise, the global BESS market is expected to expand from $7.8 billion in 2024 to $25.6 billion by 2029, at a CAGR of 26.9%, as reported by MarketsandMarkets. These trends are driven by the increasing integration of renewable energy sources, the need for grid resilience, and declining technology costs.

PowerBank’s operations have it well-positioned to capitalize on these opportunities. With a development pipeline exceeding one gigawatt (GW), the company is focused on meeting growing demand in community and commercial solar sectors. Decentralized energy solutions, such as virtual net metering and behind-the-meter systems, further enhance PowerBank’s market potential by addressing the critical need for flexible, cost-effective, and sustainable energy infrastructure. By leveraging its vertically integrated model and diversified portfolio, PowerBank stands as a key player in driving the renewable energy transition.

Leadership Team

Dr. Richard Lu, MD, MSc., MHSc., MBA, serves as President and CEO of PowerBank, bringing over 25 years of global energy experience. His leadership has been instrumental in advancing the company’s strategic initiatives across North America, Europe, and Asia, with a focus on renewable energy development and operational excellence.

Sam Sun, MBA, is the Chief Financial Officer of PowerBank. A Chartered Professional Accountant with more than 15 years of expertise in corporate finance, Mr. Sun has overseen financial strategies and internal controls across the cleantech, manufacturing, and mining sectors in Canada, the U.S., and China.

Andrew van Doorn, PE, serves as Chief Operating Officer, with nearly three decades of experience in engineering and construction. Mr. van Doorn has successfully led projects totaling over 200 MW of solar capacity and is a former Chairman of the Canadian Solar Industries Association.

Tracy Zheng, MBA, Chief Development Officer, has over 25 years of experience in brand marketing, business development, and solar project operations. She has spearheaded sales initiatives, conducted feasibility studies, and negotiated key partnerships that drive PowerBank’s growth.

Matt Wayrynen, Executive Chairman and Director, has a background in resource company management, venture capital, and mergers and acquisitions. Under his leadership, Solar Flow-Through Funds, where Mr. Wayrynen acted as CEO, was acquired by PowerBank, enhancing its asset portfolio and growth prospects.


Forward Looking Statements

This report contains forward-looking statements and forward-looking information ‎within the meaning of Canadian securities legislation (collectively, “forward-looking ‎statements”) that relate to the Company’s current expectations and views of future events. ‎Any statements that express, or involve discussions as to, expectations, beliefs, plans, ‎objectives, assumptions or future events or performance (often, but not always, through the ‎use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will ‎continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, ‎‎”projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be ‎forward-looking statements and may involve estimates, assumptions and uncertainties ‎which could cause actual results or outcomes to differ materially from those expressed in ‎such forward-looking statements. In particular and without limitation, this report ‎contains forward-looking statements pertaining to the Company’s expectations regarding its industry trends and overall market growth of the data center market; the Company’s expansion into the data center market, including its pursuit of opportunities as a developer, owner, and strategic partner in data center infrastructure; supporting the demand for high-performance, sustainable energy solutions within the sector; details of the company’s business plan including development of solar power projects, battery storage projects and EV charging projects; the completion of any contracts for, or construction of, any data center, solar power, battery storage or EV projects; the receipt of interconnection approval, permits and financing to be able to construct projects; the receipt of incentives for projects; and the size of the Company’s development pipeline. No assurance ‎can be given that these expectations will prove to be correct and such forward-looking ‎statements included in this report should not be unduly relied upon. These ‎statements speak only as of the date of this report.‎

Forward-looking statements are based on certain assumptions and analyses made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties. In making the forward looking statements included in this report, the Company has made various material assumptions, including but not limited to: obtaining the necessary regulatory approvals; that regulatory requirements will be maintained; general business and economic conditions; the Company’s ability to successfully execute its plans and intentions; the availability of financing on reasonable terms; the Company’s ability to attract and retain skilled staff; market competition; the products and services offered by the Company’s competitors; that the Company’s current good relationships with its service providers and other third parties will be maintained; and government subsidies and funding for renewable energy will continue as currently contemplated. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and the Company cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements.

Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under “Forward-‎Looking Statements” and “Risk ‎Factors” in the Company’s most recently completed Annual Information Form, and other public filings of the Company, which include: the Company may be adversely affected by volatile solar power market and industry conditions; the execution of the Company’s growth strategy depends upon the continued availability of third-party financing arrangements; the Company’s future success depends partly on its ability to expand the pipeline of its energy business in several key markets; governments may revise, reduce or eliminate incentives and policy support schemes for solar and battery storage power; general global economic conditions may have an adverse impact on our operating performance and results of operations; the Company’s project development and construction activities may not be successful; developing and operating solar projects exposes the Company to various risks; the Company faces a number of risks involving Power Purchase Agreements (“PPAs”) and project-level financing arrangements; any changes to the laws, regulations and policies that the Company is subject to may present technical, regulatory and economic barriers to the purchase and use of solar power; the markets in which the Company competes are highly competitive and evolving quickly; an anti-circumvention investigation could adversely affect the Company by potentially raising the prices of key supplies for the construction of solar power projects; foreign exchange rate fluctuations; a change in the Company’s effective tax rate can have a significant adverse impact on its business; seasonal variations in demand linked to construction cycles and weather conditions may influence the Company’s results of operations; the Company may be unable to generate sufficient cash flows or have access to external financing; the Company may incur substantial additional indebtedness in the future; the Company is subject to risks from supply chain issues; risks related to inflation; unexpected warranty expenses that may not be adequately covered by the Company’s insurance policies; if the Company is unable to attract and retain key personnel, it may not be able to compete effectively in the renewable energy market; there are a limited number of purchasers of utility-scale quantities of electricity; compliance with environmental laws and regulations can be expensive; corporate responsibility may adversely impose additional costs; the future impact of any resurgence of COVID-19 on the Company is unknown at this time; the Company has limited insurance coverage; the Company will be reliant on information technology systems and may be subject to damaging cyberattacks; the Company may become subject to litigation; there is no guarantee on how the Company will use its available funds; the Company will continue to sell securities for cash to fund operations, capital expansion, mergers and acquisitions that will dilute the current shareholders; and future dilution as a result of financings.

The Company undertakes no obligation to update or revise any ‎forward-looking statements, whether as a result of new information, future events or ‎otherwise, except as may be required by law. New factors emerge from time to time, and it ‎is not possible for the Company to predict all of them, or assess the impact of each such ‎factor or the extent to which any factor, or combination of factors, may cause results to ‎differ materially from those contained in any forward-looking statement. Any forward-‎looking statements contained in this report are expressly qualified in their entirety by ‎this cautionary statement.‎

PowerBank Corporation (NASDAQ: SUUN), closed Friday's trading session at $1.3, off by 2.2556%, on 60,375 volume. The average volume for the last 3 months is 203,795 and the stock's 52-week low/high is $1.23/$6.43.

Recent News

SEGG Media Corp. (NASDAQ: SEGG)

The QualityStocks Daily Newsletter would like to spotlight SEGG Media Corp. (NASDAQ: SEGG).

SEGG Media (NASDAQ: SEGG, LTRYW) , owner of Sports.com, Concerts.com and Lottery.com, announced the launch of the Quadrant Speedway Collection, the first major apparel drop since its strategic investment in Veloce Media Group and Veloce's acquisition of Quadrant, the motorsport and lifestyle brand co-founded by Formula 1 driver Lando Norris. The collection, blending motorsport heritage with streetwear aesthetics, debuted with Norris in the F1 paddock ahead of his pole position and podium finish at the Belgian Grand Prix. Chairman and CEO Matthew McGahan said the launch reflects SEGG Media's vision to power next-generation sports, fashion and fandom through strategic investments and the reach of Veloce's platform, which drives more than 750 million monthly views and 55 million subscribers.

To view the full press release, visit https://ibn.fm/4ATxl

SEGG Media (NASDAQ: SEGG, LTRYW) , owner of Sports.com, Concerts.com and Lottery.com, announced the relaunch of its Aganar operations in Mexico under its license to sell lottery draw games offered by the Mexican National Lottery. Aganar, operated by subsidiary Medios Electrónicos Y De Comunicación, has been a licensed online retailer in Mexico since 2007. The reactivation is expected to generate $5.2 million in revenue with an 18% annual growth trajectory and serves as the first step in SEGG Media's broader Latin America expansion strategy. Chairman and CEO Matthew McGahan said the relaunch demonstrates tangible progress in the turnaround of Lottery.com and positions the company to scale operations globally, supported by $450 million in committed financing facilities.

To view the full press release, visit https://ibn.fm/AlmAw

SEGG Media Corp. (NASDAQ: SEGG; LTRYW) is a global sports, entertainment, and gaming company redefining how audiences connect with content through immersive technology and ethical engagement. Formerly known as Lottery.com Inc., the company recently completed a comprehensive corporate transformation, rebranding as SEGG Media (short for Sports Entertainment Gaming Global Media) to reflect its new strategic direction and structural overhaul.

With a mission to fuse real-time experiences, fan-first platforms, and responsible innovation, SEGG Media operates at the intersection of sports, entertainment, and gaming. Its business model is built around three synergistic verticals, each designed to scale globally while delivering meaningful value to fans, partners, and shareholders.

From sim racing and esports to live event streaming and charitable gaming, SEGG Media is building a next-generation platform that redefines how audiences interact with their favorite content and communities.

The company is headquartered in Fort Worth, Texas.

Portfolio

SEGG Media’s operations are structured across three core verticals: Sports.com, Entertainment, and Lottery.com.

  • Sports.com is SEGG’s global hub for immersive sports media, covering sim racing, football, motorsports, and athlete-led content. The vertical includes Sports.com Studios, Sports.com Media, and Nook, each focused on original storytelling and fan-driven experiences. In June 2025, SEGG announced plans to acquire a 51% stake in the sports and technology assets of GXR World to launch the Sports.com Super App, a first-of-its-kind platform combining live streaming, e-commerce, community chat, real-money and fantasy gaming, and sports news. Built on GXR’s tech stack, which already draws over one million monthly active users, the Super App is expected to debut in Q3 2025 with an initial focus on soccer and motorsports.
  • The Entertainment pillar includes AI-driven event streaming, music and fashion media, and hybrid live experiences. As part of its acquisition-led growth model, SEGG is advancing a proposed deal to acquire DotCom Ventures Inc., owner of Concerts.com and TicketStub.com, to build out ticketing, event distribution, and direct-to-fan monetization infrastructure. This initiative aligns with SEGG’s five-year plan to unify content, commerce, and fan engagement under one platform, supported by a $100 million financing facility activated in May 2025.
  • Lottery.com, SEGG’s ethical gaming division, delivers domestic and international lottery access, iGaming, instant wins, sports betting, charitable gaming through properties such as WinTogether, and syndicated results data to more than 800 publishers through Tinbu. With compliance issues resolved and new operating structures in place, the platform is being relaunched globally through Lottery.com International.

Together, these three verticals enable SEGG Media to unify fragmented fan experiences into a fully integrated global ecosystem—where sports, gaming, content, and commerce converge.

Market Opportunity

The global sports betting industry is undergoing rapid expansion as digital adoption accelerates and new markets open to regulation. According to Grand View Research, the sports betting market was valued at $100.9 billion in 2024 and is projected to reach $187.39 billion by 2030, growing at a compound annual growth rate of 11% from 2025 to 2030. This growth is fueled by increased internet penetration, widespread mobile usage, and rising interest in real-time, interactive fan experiences.

Beyond sports betting, SEGG Media also operates in the high-growth arenas of streaming, esports, and AI-powered content delivery. These adjacent markets are seeing double-digit global growth as fans demand more immersive, on-demand, and participatory forms of entertainment. With its diversified platform and strategic positioning across three converging verticals, SEGG Media is built to capitalize on multiple long-term secular trends and unlock scalable revenue opportunities.

Leadership Team

Matthew McGahan, Chief Executive Officer and Chairman, joined the company in October 2022. Since then, he has played a central role in stabilizing operations, restructuring the organization, and guiding its rebrand to SEGG Media. McGahan brings a mix of entrepreneurial drive and philanthropic leadership, having founded the UK-based charity Mask Our Heroes during the COVID-19 pandemic and previously built and sold the Harley-Davidson dealership Magic Automotive Group.

Tim Scoffham, CEO of Sports.com Media and Lottery.com International, brings over 20 years of leadership experience across gaming, media, and digital sports entertainment. Appointed following a successful consultancy period, Scoffham now leads SEGG’s global growth strategy for its iGaming and sports media divisions. He is focused on expanding international operations, aligning media and technology platforms, and driving revenue across high-growth jurisdictions while strengthening regulatory partnerships.

Investment Considerations
  • SEGG Media has completed a comprehensive corporate transformation, including rebranding, structural realignment, and strategic repositioning.
  • The company operates across three synergistic verticals with scalable revenue potential: Sports.com, Entertainment, and Lottery.com.
  • A $100 million financing facility is in place to support its acquisition-driven five-year growth plan.
  • The upcoming launch of the Sports.com Super App is expected to redefine fan engagement across soccer, motorsports, and beyond.
  • SEGG is executing a global expansion strategy through acquisitions such as GXR World and DotCom Ventures.

SEGG Media Corp. (NASDAQ: SEGG), closed Friday's trading session at $0.9301, off by 4.2319%, on 650,992 volume. The average volume for the last 3 months is 970,557 and the stock's 52-week low/high is $0.2202/$2.645.

Recent News

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF)

The QualityStocks Daily Newsletter would like to spotlight Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF).

Lahontan's Santa Fe Mine produced 359,202 ounces of gold and 702,067 ounces of silver between 1988-1995 using low-cost heap leach operations, establishing proven mineralization and processing methods

The current 2-million-ounce resource at cash costs of $1,230 per ounce positions the company for profitable production as gold reaches critical mineral status under the new administration

Fast-track permitting strategy targeting early 2027 production leverages existing infrastructure and pro-mining regulatory environment in Nevada's Walker Lane district

The gold mining sector faces a fundamental challenge that extends beyond typical commodity cycles: the increasing difficulty and cost of bringing new mines into production. While gold prices have surged to record levels and mining-friendly policies gain political support, many exploration companies struggle with the lengthy timelines, regulatory complexities, and capital requirements needed to advance greenfield projects from discovery to production. However, a subset of opportunities exists that bypasses many of these traditional development barriers: past-producing mines with established infrastructure, proven processing methods, and existing resource bases that can be rapidly advanced back into production. That's exactly the opportunity represented by Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF), which controls the Santa Fe Mine project in Nevada's prolific Walker Lane mineral district.

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) is a Canadian mine development and exploration company advancing a portfolio of gold and silver assets in Nevada’s Walker Lane, one of the world’s most productive and mining-friendly regions. Through its U.S. subsidiaries, the company controls four gold and silver properties in Nevada, three of which are 100%-owned and one controlled via a low-cost option to acquire full ownership. With a clear near-term path to production, Lahontan is focused on unlocking oxide gold and silver value from past-producing, infrastructure-rich projects.

The company’s mission is to responsibly develop and expand its oxide resources while minimizing capital intensity and maximizing economic returns. Leveraging a strong technical team with a track record of advancing projects and building mines, Lahontan is focused on growing gold and silver resources and hitting permitting milestones across multiple sites. Its strategy prioritizes scalability, efficiency, and timely value realization for shareholders.

By maintaining full project ownership and a capital-light development model, Lahontan Gold is positioned to rapidly transition from development to production.

The company is headquartered in Toronto, Ontario.

Projects

Santa Fe Mine

The 26.4 km² Santa Fe Mine is Lahontan’s flagship asset and core development priority. A past-producing open-pit, heap-leach gold and silver operation, Santa Fe historically yielded more than 359,000 ounces of gold and 702,000 ounces of silver between 1988 and 1995. The site benefits from established infrastructure—including power, water, and road access—and more than 79% of its known resources are unencumbered by royalties.

A 2024 NI 43-101 resource estimate outlines 1.54 million ounces of gold equivalent (AuEq) in the Indicated category and 0.41 million ounces Inferred, all pit-constrained. Oxide resources average among the highest grades in the state and are distributed across five known deposits. A 2025 Preliminary Economic Assessment (PEA) projects strong economic returns, including an after-tax NPV5% of $200 million, a 34.2% internal rate of return (IRR), and average annual production of approximately 50,000 ounces AuEq over an eight-year mine life.

Permitting is well underway for both the Exploration and Mine Plans of Operation, covering over 12 km² and more than 700 drill holes. The company is targeting construction permits in late 2026 and continues to pursue oxide resource expansion and metallurgical optimization, particularly within the Slab-Calvada corridor.

West Santa Fe

West Santa Fe lies just 13 kilometers from the flagship and is being explored as a potential satellite operation. The project is defined by a shallow, oxide-dominant gold-silver system with a conceptual target of 0.5 to 1.0 million ounces AuEq based on historic drilling and recent surface sampling, which returned up to 2.61 g/t Au and 899 g/t Ag (14.6 g/t AuEq). A 6,300-meter Phase One reverse circulation drill program is scheduled for 2025 to validate historical data and support a maiden resource estimate. Development is streamlined under a low-cost option agreement and a rapid permitting path via Notice of Intent.

Moho and Redlich

The Moho and Redlich projects provide additional longer-term upside within Lahontan’s portfolio. Moho features high-grade, oxidized epithermal veins with historic production at grades of 20–25 g/t Au and 300 g/t Ag. A 2019 core drill program confirmed the presence of high-grade mineralization at depth. Redlich, located along trend from the historic Candelaria silver mine, hosts disseminated Ag mineralization in epithermal veins and hydrothermal breccias but remains untested by drilling. While no near-term programs are currently disclosed, both assets represent future exploration optionality.

Market Opportunity

Lahontan Gold operates in Nevada, consistently ranked the top global mining jurisdiction by the Fraser Institute due to its transparent permitting process, legal stability, and established infrastructure. Nevada produces over 4.5 million ounces of gold annually, generating approximately $9 billion in value, and ranks fifth globally in total gold production.

According to the World Gold Council, total gold demand in Q1 2025 reached 1,206 tonnes, up 1% year-over-year, marking the strongest first quarter since 2016. Central banks added 244 tonnes to reserves, a slight slowdown from the prior quarter but well within the strong buying range observed over the past three years. Meanwhile, silver demand is supported by strong industrial usage in solar panels, electric vehicles, and semiconductors, with long-term deficits forecast in the physical silver market.

With macro-driven demand for gold, technology-driven silver consumption, and strong institutional buying across both metals, Lahontan is uniquely positioned to capitalize through its portfolio of oxide-focused projects in a top-tier jurisdiction—offering near-term production potential and longer-term resource expansion.

Leadership Team

Kimberly Ann, Founder, CEO, President & Executive Chair, is a veteran mining executive with a track record of founding and scaling junior resource companies. She has raised over $210M in financing and led the $340M buyout of Prodigy Gold. Her prior roles include CFO of PPX Mining and founder of Latin America Resource Group, which merged with Carube Copper to form C3 Metals.

Brian Maher, Founder and VP of Exploration, is an economic geologist with more than 45 years of experience. He previously led Prodigy Gold as CEO, where he helped develop the Magino gold project before its $341M acquisition. His career includes senior roles at ASARCO, Hochschild Mining, and PPX Mining, where he oversaw exploration and production in the Americas.

John McNeice, Chief Financial Officer, is a Chartered Professional Accountant with three decades of experience in public company reporting. He has served as CFO for seven public resource companies and played a key role in Ur-Energy Inc.’s TSX IPO and $150M in financings. He also serves as CFO for Gold79 Mines, C3 Metals, and Northern Graphite Corp.

Current Initiatives
  • Commencing Summer gold and silver resource expansion drilling at Santa Fe
  • Optimizing Preliminary Economic Assessment reflecting +$3,000 gold price
  • Exploration Plan of Operations heading into NEPA stage with approval expected Q4 2025
  • Targeting late 2026 mining permit and breaking ground at Santa Fe in 2027
Investment Considerations
  • The Santa Fe Mine hosts 1.95 million ounces of pit-constrained gold equivalent resources across Indicated and Inferred categories.
  • A 2025 Preliminary Economic Assessment for Santa Fe outlines an after-tax NPV5% of $200 million and a 34.2% IRR based on spot pricing.
  • All four projects are 100%-owned or under low-cost acquisition agreements, with development centered in Nevada, the world’s top mining jurisdiction.
  • Near-term catalysts include Santa Fe permitting milestones, West Santa Fe’s maiden drill program, and an updated economic study.
  • The company is led by a proven team with multiple M&A exits and extensive experience in advancing heap-leach gold operations.

Lahontan Gold Corp. (OTCQB: LGCXF), closed Friday's trading session at $0.07, off by 4.1096%, on 1,078,860 volume. The average volume for the last 3 months is 461,320 and the stock's 52-week low/high is $0.0143/$0.09049.

Recent News

BluSky AI Inc. (OTC: BSAI)

The QualityStocks Daily Newsletter would like to spotlight BluSky AI Inc. (OTC: BSAI).

BluSky AI Inc. (OTC: BSAI) is pioneering the next generation of AI infrastructure through modular, rapidly deployable data centers that meet the escalating compute demands of artificial intelligence, machine learning, and high-performance computing. The company’s mission is to empower AI innovators by eliminating infrastructure bottlenecks and accelerating time-to-compute with energy-efficient, scalable solutions.

Rather than betting on individual AI applications, BluSky AI addresses the universal need for compute power—positioning itself as a foundational layer in the AI revolution. Its infrastructure-first approach enables clients to focus on innovation while the company delivers the critical backbone powering tomorrow’s breakthroughs.

BluSky AI is headquartered in Salt Lake City, Utah.

Products

BluSky AI’s core offering is its SkyMod series of modular data centers—pre-assembled, scalable compute units designed specifically for AI workloads. The flagship SkyMod One delivers 1 MW of compute power in a compact 1,400-square-foot footprint, while the SkyMod XL offers 1.7 MW in 3,000 square feet. These units are fully assembled off-site, tested, and shipped ready for plug-and-play deployment either on BluSky-owned land or client facilities.

SkyMod modules integrate NVIDIA GPUs and are optimized for high-density AI applications such as generative AI, large language models, inference engines, and scientific computing. Built for rapid scaling and high efficiency, each system includes advanced cooling, secure infrastructure, and dynamic workload balancing to support evolving client needs.

The company’s data centers are engineered for sustainability, incorporating renewable energy sources like solar, wind, and geothermal where available. By deploying on powered land assets, BluSky AI shortens lead times and lowers costs, creating a fast, flexible alternative to traditional monolithic data centers.

Market Opportunity

The global data center market was valued at $347.6 billion in 2024 and is projected to reach $652.0 billion by 2030, growing at a CAGR of 11.2%, driven by the rapid expansion of AI, machine learning, and IoT adoption, according to Grand View Research. As enterprises demand faster, more scalable compute solutions, modular infrastructure like BluSky AI’s SkyMod series offers a compelling alternative to legacy data center models.

With North America accounting for over 40% of the global market and the U.S. expected to grow at a 10.7% CAGR from 2025 to 2030, BluSky AI is well-positioned to capture demand for AI-optimized infrastructure that can be deployed rapidly and cost-effectively. By focusing on GPU-centric, modular deployments tied to energy infrastructure, the company addresses a growing gap between compute demand and deployment speed in the AI era.

Leadership Team

Trent D’Ambrosio, Chief Executive Officer, is a seasoned executive with a track record in telecommunications, hedge fund management, and natural resource development. He previously sold the first transatlantic fiber cable, built a successful gold mining company, and now leads BluSky AI with a vision to revolutionize AI infrastructure through strategic energy integration and rapid deployment.

Julien Bedard, Chief Technology Officer, is a pioneering technologist known for launching the first Bitcoin escrow and anti-fraud service. At BluSky AI, he oversees cloud architecture, cybersecurity, infrastructure automation, and the development of AI-native data center technology, ensuring scalability and resilience across deployments.

Dan Gay, Chief Operating Officer, has Fortune 500 executive leadership in telecom, technology, and energy, as well as start-up experience with finance and blockchain companies. At MCI and Qwest, he launched new service and sales centers, and directed National Account Sales. He has been a successful CMO in brand creation, product development, partnerships, and revenue generation programs to expand company awareness, sales, and revenue.

Investment Considerations
  • BluSky AI delivers mission-critical infrastructure supporting AI, ML, and HPC applications.
  • SkyMod modules are prefabricated, scalable, and optimized for rapid plug-and-play deployment.
  • The company’s data center designs emphasize sustainability with support for renewable energy.
  • BluSky’s infrastructure-first model addresses universal AI compute needs across industries.
  • A veteran leadership team combines expertise in telecom, finance, and advanced technologies.

BluSky AI Inc. (OTC: BSAI), closed Friday's trading session at $12, up 50.9434%, on 31,138 volume. The average volume for the last 3 months is 6,770 and the stock's 52-week low/high is $0.118/$17.97.

Recent News

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)

The QualityStocks Daily Newsletter would like to spotlight LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF).

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) is a Canadian exploration and development company advancing the district-scale Swanson Gold Project in Québec’s prolific Abitibi Gold Belt and progressing toward the near-term restart of gold production at its wholly owned Beacon Gold Mill. The company’s strategy centers on consolidating strategic land packages—highlighted by its flagship Swanson Gold Project, a 160 km² district-scale property that includes several prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. The company is leveraging its 100%-owned, fully permitted and recently refurbished Beacon Gold Mill to transition from explorer to near-term gold producer—a key inflection point that typically triggers a market re-rating, further bolstered by current rising gold market prices. By processing material from Swanson and offering custom milling to regional projects, LaFleur aims to generate cash flow with minimal capital outlay, targeting annual gold production of up to 15,000 to 20,000 ounces by early 2026.

LaFleur’s vision is to evolve into an intermediate gold producer by capitalizing on strong market conditions and Québec’s rich mining infrastructure. The location, in the world-class Abitibi Gold Belt, and its infrastructure advantage, positions LaFleur for regional consolidation, strategic partnerships, or acquisition interest. Its mission emphasizes efficient value creation through methodical exploration, low-cost asset advancement, and opportunistic acquisitions—including land and deposits from Monarch Mining, Abcourt Mines, and Globex Mining.

Québec ranks among the world’s top mining jurisdictions, offering access to flow-through capital and regulatory stability. LaFleur’s integrated strategy—combining exploration at Swanson, a permitted mill at Beacon, and potential custom milling agreements—supports a streamlined path to near-term production.

LaFleur Minerals is headquartered in Vancouver, British Columbia.

Projects

LaFleur Minerals’ operations focus on two strategically located assets in the Abitibi Gold Belt: the Swanson Gold Project and the Beacon Gold Mill and Mine. These projects leverage the region’s world-class mining infrastructure and high-grade gold potential to drive the company’s transition to production.

Swanson Gold Project

The Swanson Gold Project spans 16,600 hectares and hosts the Swanson, Bartec, and Jolin gold deposits along a major structural break in the Abitibi Gold Belt. The 2024 Mineral Resource Estimate for the Swanson deposit outlines 123,400 oz of gold in Indicated category (2.1 million tonnes at 1.8 g/t) and 64,500 oz in Inferred category (872,000 tonnes at 2.3 g/t). Located 66 km north of Val-d’Or, the Project is accessible by road and rail and benefits from more than 36,000 meters of historical drilling, along with existing infrastructure including an 80-meter decline portal.

Recent work—including airborne magnetics, soil sampling, and Induced Polarization surveys—has identified multiple high-priority targets and resulted in several high-grade gold assay results, including a grab sample grading 11.71 g/t Au at Jolin, which points to significant upside as the Company prepares to test multiple new zones.

LaFleur has defined over 50 drill targets at Swanson and nearby prospects (Bartec, Jolin, Marimac) and is completing a minimum 5,000-metre diamond drilling beginning in June 2025. LaFleur Minerals has also initiated permitting for a 100,000-tonne surface bulk sample averaging 1.89 g/t Au, which it plans to process at the Beacon Gold Mill as part of a near-term production strategy.

Beacon Gold Mill

LaFleur’s 100%-owned Beacon Gold Mill is a fully refurbished and permitted mill and tailings storage facility capable of processing 750 tonnes per day (tpd), with potential expansion to 1,800 tpd, with access to numerous nearby gold deposits that could be prime sources of ore. Located only 60 km from Swanson, it underwent a $20 million upgrade by Monarch Mining in 2022 and has been under care and maintenance since early 2023. LaFleur is finalizing a C$5-6 million restart plan, ramping up production by late 2025 into early 2026, processing Swanson mineralized material and assessing custom milling opportunities for regional deposits, creating multiple potential revenue streams.

The Beacon Gold Mill is a de-risked, proven asset that benefits from existing infrastructure, including access to roads, power, and skilled labor, and further enhances the overall value proposition of LaFleur by providing a clear path to production and potential revenue-generation.

Market Opportunity

LaFleur Minerals is targeting the gold mining and processing market in Québec’s Abitibi Gold Belt, one of the world’s most productive gold regions. Its fully permitted Beacon Gold Mill, with a 750 tpd capacity and authorization to process 1.8 million tonnes of tailings, is strategically positioned to handle material from LaFleur’s Swanson Gold Project and to offer custom milling for nearby deposits such as Granada Gold. The company projects annual production of over 30,000 ounces of gold once in full production, with potential for significant revenue generation based on prevailing market prices.

Global demand for gold remains robust, driven by geopolitical risk, inflation hedging, and central bank accumulation. The World Gold Council forecasts 3-5% annual demand growth through 2030, with average prices expected between $3,200 and $3,500/oz. Within this environment, Québec’s top-tier mining jurisdiction—ranked fifth globally by the Fraser Institute in 2023—offers streamlined permitting and access to flow-through capital. LaFleur’s low-cost Beacon restart (C$5-6 million) and proximity to more than 100 active and historical mines position the company to fill a growing need for small-to-medium scale custom milling.

At Swanson, LaFleur plans to grow its current 187,900-ounce resource toward 1 million ounces through its 2025 drilling program. This hub-and-spoke strategy, leveraging centralized milling and strong local infrastructure, reduces development risk and strengthens LaFleur’s foothold in one of the most attractive gold belts in the world.

Leadership Team

Kal Malhi, Chairman, is a successful entrepreneur and the Founder of Bullrun Capital Inc., where he has raised over $300 million for early-stage companies across the mining, oil and gas, biomedical, agriculture, and technology sectors. He specializes in advancing academic research into commercial ventures and public listings, with more than two decades of capital markets and leadership experience.

Paul Ténière, M.Sc., P.Geo., Chief Executive Officer, is a seasoned mining executive and Professional Geologist with over 25 years of global experience in the development of precious and base metals, critical minerals, and metallurgical coal projects. Mr. Ténière is an expert in NI 43-101 and S-K 1300 disclosure standards and has held senior roles including President & CEO, SVP Exploration, and Director with several publicly traded mining companies. Mr. Ténière also worked at the Toronto Stock Exchange (TSX) and TSX Venture Exchange as a mining expert and Senior Listings Manager listing dozens of mining companies and ensuring listed issuers met their corporate governance and compliance and disclosure requirements.

Harry Nijjar, Chief Financial Officer and Corporate Secretary, serves as Managing Director at Malaspina Consultants Inc., providing CFO and strategic financial advisory services to companies across multiple industries. He holds a CPA CMA designation from the Chartered Professional Accountants of British Columbia and a Bachelor of Commerce from the University of British Columbia.

Louis Martin, P.Geo., Technical Advisor and Exploration Manager, is a veteran geologist with more than 40 years of exploration experience. He has played key roles in significant gold and base metal discoveries, including the Louvicourt (1989) and West Ansil (2005) deposits—both recognized by the Association de l’Exploration Minière du Québec (AEMQ). He previously served as VP Exploration at Clifton Star Resources, where he led the pre-feasibility study for the 4.5 million-ounce Duparquet Gold Project. He is a registered geologist in Québec and Ontario.

Tara Asfour, Corporate Communications, Investor Relations and Strategy, is an experienced executive consultant with over 12 years of management, investor relations, communications and marketing experience, specialized in capital markets. In her previous positions, Ms. Asfour has led over US$550 million worth of fundraising and strategic development initiatives. Ms. Asfour holds a Master’s degree in Business Management, a Financial Markets Certificate from Yale University, and a Certificate in Alternative Investments from HBS. Previous positions include investor relations executive at Red Pine Exploration, Fancamp Exploration, Communications Director at Dominion Water Reserves (now Prime Drink Group Corp) and advisor to various other publicly listed firms in the resource and technology sectors. Ms. Asfour holds the Institute for Governance (IGOPP) Certification in Governance, Ethics in Business Environment and Corruption Prevention.

Peter Espig, Strategic Advisor and Consultant, has served as Vice-President at Goldman Sachs Japan in both the Principal Finance and Securitization Group and the Asia Special Situations Group, where his team participated in more than $10 billion in structured deals, capital raises, and cross-border transactions. Prior to Goldman Sachs, he was Vice-President at Olympus Capital, a New York-based private equity firm, where he focused on corporate restructurings, investment analysis, and international financing negotiations. He also played a pioneering role in some of the earliest SPAC transactions, totaling over US$1.2 billion, and brings deep experience in disciplined capital deployment and turnaround execution. Since 2013, Mr. Espig has served as President and CEO of Nicola Mining Inc. and is a board member of ESGold Corp and First Lithium Minerals. Mr. Espig holds a Bachelor of Arts from the University of British Columbia and an MBA from Columbia Business School, where he was a Chazen International Scholar. He has served on various public boards and was recognized among Industry Era’s “Top 10 Admired Leaders” in 2023.

Jean Lafleur, Senior Technical Advisor, is a Professional Geologist (Québec) with 45 years of experience in Canada and internationally including USA, Mexico, Latin America, Ireland, Spain and Africa. Earlier in his career he worked with Newmont, Falconbridge, Dome Mines, and Placer Dome and has been a C-suite executive for a number of junior exploration companies. Jean has remained active as a technical, management, and financing consultant with junior explorers since the early 2000’s through his own geological consultancy firm and throughout his career has led a number of teams in the discovery of precious and base metals, nickel, PGE’s, uranium, and iron deposits. Jean’s expertise includes mining company and project evaluations, audits, technical reporting, exploration program planning and execution, and research and development with a strong focus on Québec. Jean currently acts as a Senior Consultant, North America for Appian Capital Advisory LLP, a mining-focused private equity firm based in London, UK where through his extensive professional network he sources and presents potential mining transactions in North America to the Appian team for investment opportunities.

Investment Considerations
  • LaFleur Minerals’ fully permitted Beacon Gold Mill, acquired in 2024 and refurbished by its previous owner, offers a low-cost path to production with an estimated restart budget of C$5-6 million.
  • The Swanson Gold Project’s 2024 mineral resource estimate of 123,400 oz indicated and 64,500 oz inferred, alongside a 5,000-meter drilling program, supports the company’s goal of growing the resource toward 1 million ounces.
  • Consolidation of 15,290 hectares, including acquisitions from Monarch Mining, Abcourt Mines, and Globex Mining, has positioned LaFleur as a formidable exploration company in the Abitibi Gold Belt.
  • LaFleur’s hub-and-spoke development model, centered on its Beacon Mill, supports custom milling opportunities and enhances value from regional partnerships.
  • A highly experienced leadership team with over 100 years of combined expertise across mining, finance, and capital markets underpins the company’s transition from exploration to production.

LaFleur Minerals Inc. (OTCQB: LFLRF), closed Friday's trading session at $0.4009, up 8.955%, on 21,367 volume. The average volume for the last 3 months is 116,370 and the stock's 52-week low/high is $0.0139/$1.65.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) s a critical metals technology company developing scalable rare earth element (“REE”) refining infrastructure in North America. Originally founded in 2006 as a mineral exploration company, Ucore has since evolved into a processing technology innovator focused on commercializing its proprietary RapidSX™ platform under a $18.4 million contract from the U.S. Department of Defense, with additional support from Natural Resources Canada. The company’s flagship deployment is the Louisiana Strategic Metals Complex (“SMC”), with additional SMCs planned to follow.

Ucore’s mission is to help reestablish a domestic REE supply chain by offering competitive, modular processing solutions that reduce dependence on China. Supported by government funding, private capital, and engineering partnerships, Ucore aims to meet growing demand for rare earth oxides in electric vehicles, defense systems, and advanced energy technologies.

The company is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Separation Technology

RapidSX™ is Ucore’s proprietary rare earth separation platform, delivering three times faster processing than traditional solvent extraction (SX) methods. Its current demonstration program in Kingston, Ontario, is being conducted under contract with the U.S. Department of Defense to prove commercial readiness for processing both heavy and light REEs. The project is also supported by Natural Resources Canada.

RapidSX™ employs a column-based design that eliminates the need for powered mixer-settlers, enabling a smaller facility footprint, quicker commissioning, and lower CAPEX and OPEX. The platform is adaptable to light and heavy REE feedstocks and is structured for modular scale-up.

The 52-stage RapidSX™ Commercial Demonstration Plant in Kingston, Ontario—operated in partnership with Kingston Process Metallurgy—has logged thousands of runtime hours and is currently processing rare earth feedstock further to the company’s U.S. Department of Defense contract. In January 2025, Ucore secured a $500,000 non-dilutive grant from Ontario’s Critical Minerals Innovation Fund to support the advancement of the Kingston facility and, in the words of Ontario Mines Minister George Pirie, “build a secure supply chain ready to fuel the technologies of tomorrow.”

Strategic Metals Complex – Louisiana

Ucore has selected an 80,800-square-foot brownfield site within the England Airpark in Alexandria, Louisiana, as the location for its first commercial rare earth refining facility. The Louisiana SMC is expected to scale from 2,000 tonnes per annum (TPA) of total rare earth oxides initially to 5,000 TPA, with potential to ultimately reach 7,500 TPA.

The facility benefits from Foreign Trade Zone (FTZ) status, reducing tariff burdens on imported inputs and enhancing logistics efficiency. In addition to these structural advantages, the state of Louisiana has outlined an incentive package valued at $15 million, including a $900,000 infrastructure grant and $360,000 in additional local support. The project is expected to create 100 family-wage jobs and has received strong support from federal and state officials.

To date, Ucore has secured $2.3 million in milestone payments under its $18.4 million OTA award from the U.S. Department of Defense. In early 2024, the company also secured C$2.16 million in private investment from Hondo Private Equity to support its commercialization efforts.

Bokan-Dotson Ridge REE Project – Alaska

Ucore maintains 100% ownership of the Bokan-Dotson Ridge heavy REE project in Southeast Alaska. A Preliminary Economic Assessment was completed in January 2013. The Alaska Industrial Development and Export Authority (AIDEA) has authorized $145 million in bond financing under SB99 (2014) to support future development.

While Bokan remains a long-term asset, Ucore continues to advance it at a measured pace, complementing its near-term focus on commercial rare earth refining and oxide production at the Louisiana SMC.

Market Opportunity

According to Grand View Research, the global rare earth elements market was estimated at $3.95 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030. The market outlook remains strong, fueled by the growing demand for permanent magnets and catalysts in the automotive sector.

In March 2025, President Trump invoked the Defense Production Act to prioritize domestic critical mineral production, signaling a national mandate to reduce reliance on “hostile foreign powers’ mineral production.” One month later, the Chinese government enacted immediate export restrictions on seven key rare earth elements, including dysprosium and terbium, further intensifying pressure on Western nations to develop secure and independent supply chains. This underscores the strategic value of Ucore’s domestic separation infrastructure.

Leadership Team

Pat Ryan, P.Eng., Chairman and CEO, is the founder of Neocon International, a leading automotive OEM supplier. He brings over 25 years of experience in global supply chain innovation and has led Ucore since 2014 in its strategic pivot toward rare earth processing.

Peter Manuel, Vice President, CFO & Corporate Secretary, has served as Ucore’s financial lead for 14 years. Trained as a Chartered Accountant, with extensive experience across Canada, England, and Ireland, Mr. Manuel has advised public and private entities on strategic planning, treasury, and assurance.

Michael Schrider, MEng, P.E., Vice President & COO, is a multidisciplinary engineer with over 30 years of experience. He founded and operated engineering firms SAi and ABD and has overseen all phases of Ucore’s technical development since 2016.

Geoff Atkins, Vice President of Business Development, has 30 years of mining experience and was instrumental in advancing both Lynas’ Mt. Weld and Vital Metals’ Nechalacho REE operations. He brings deep operational knowledge and leads feedstock strategy at Ucore.

Investment Considerations
  • The company is closely aligned with national policy, receiving funding from both the U.S. Department of Defense ($18.4 million) and Natural Resources Canada (C$4.3 million).
  • Ucore’s RapidSX™ platform promises to deliver faster REE separation than traditional SX and is being commercialized at scale.
  • The Louisiana SMC aims to ramp to 7,500 TPA rare earth oxide production and benefits from FTZ status, DoD funding, and private equity backing.
  • Ucore’s 100%-owned Bokan-Dotson Ridge project remains a potentially valuable strategic heavy REE resource supported by a $145M AIDEA bond.
  • As China imposes REE export restrictions and the U.S. escalates domestic production policy, Ucore is positioned as a secure Western alternative.

Ucore Rare Metals Inc. (OTCQX: UURAF), closed Friday's trading session at $1.378, up 8.0784%, on 480,987 volume. The average volume for the last 3 months is 616,940 and the stock's 52-week low/high is $0.33/$1.64.

Recent News

Lantern Pharma Inc. (NASDAQ: LTRN)

The QualityStocks Daily Newsletter would like to spotlight Lantern Pharma Inc. (NASDAQ: LTRN).

Lantern Pharma Inc. (NASDAQ: LTRN) is a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development. Through its proprietary platform, RADR® (Response Algorithm for Drug Positioning & Rescue), Lantern is advancing a pipeline of precision cancer therapies. The company has gained 11 FDA Designations for its portfolio of drug candidates including: Fast Track, Orphan and Pediatric Rare Disease. The company’s data-driven approach enables rapid identification of promising drug candidates and the design of targeted clinical trials for specific patient subpopulations and cancer types.

Lantern’s vision is to transform cancer treatment by integrating large-scale genomics, AI-based biomarker discovery, and preclinical modeling to accelerate the development of oncology drugs. The company’s pipeline includes three lead small molecule candidates and an antibody-drug conjugate (ADC) program across 12 cancer indications, supported by strategic collaborations with global research institutions and clinical partners. The company has three active clinical trials enrolling patients with multiple clinical milestones expected throughout the next twelve months.

The company’s mission is centered on transforming the cost and pace of developing innovative therapies for patients with genetically defined cancers or limited treatment options. Lantern is also advancing brain and CNS cancer drug development through its wholly owned subsidiary, Starlight Therapeutics.

The company is headquartered in Dallas, Texas.

Product Portfolio

Lantern Pharma’s product pipeline consists of three lead candidates—LP-300, LP-184, and LP-284—and a preclinical ADC program. All are guided by insights from the RADR® platform, which has grown to incorporate over 200 billion oncology-specific data points.

LP-300 is in a Phase 2 trial (Harmonic™) for non-small cell lung cancer (NSCLC) in never smokers. The trial evaluates LP-300 in combination with carboplatin and pemetrexed and has shown a clinical benefit rate of 86% and an objective response rate of 43% in its initial cohort. The study is enrolling 90 patients across the U.S., Japan, and Taiwan (NCT05456256).

LP-184 is in a Phase 1a trial for advanced solid tumors and GBM (NCT05933265). The compound has received FDA Fast Track Designations for GBM and triple-negative breast cancer (TNBC), as well as four Rare Pediatric Disease Designations. Upcoming Phase 1b/2 trials are planned for TNBC (monotherapy and with olaparib) and for NSCLC patients with KEAP1/STK11 mutations in combination with nivolumab and ipilimumab.

LP-284 is currently in a Phase 1 trial for relapsed or refractory non-Hodgkin’s lymphoma (NHL) and other solid tumors (NCT06132503). The drug candidate has demonstrated complete tumor suppression in preclinical models of mantle cell lymphoma resistant to Ibrutinib and bortezomib and showed synergistic activity with rituximab in high-grade B-cell lymphoma models.

Lantern’s ADC program is based on cryptophycin conjugates and is undergoing preclinical evaluation, showing sub-nanomolar potency and improved targeting in HER2-expressing models.

The company has also launched Starlight Therapeutics, focused on CNS cancers, where STAR-001 (LP-184 for CNS cancers) is advancing toward a Phase 1b/2 trial in glioblastoma and pediatric brain cancers, including ATRT, supported by Rare Pediatric Disease Designations and preclinical validation from Johns Hopkins.

Market Opportunity

Lantern Pharma is focused on oncology indications with significant unmet medical need and multi-billion-dollar commercial potential.

  • LP-300 targets non-small cell lung cancer in never smokers, a patient population estimated at over 150,000 cases globally and representing a market opportunity exceeding $4 billion annually.
  • LP-184 is positioned for use in DDR-deficient tumors such as pancreatic, bladder, and triple-negative breast cancers, which collectively represent a U.S. market opportunity estimated at over $10 billion annually. Opportunities in targeted DDR-deficient tumors include the KEAP1/STK11 mutant NSCLC population targeted by LP-184, with a market potential of over $2 billion annually, and TNBC, which alone represents a $4 billion global market given its aggressiveness and high brain metastasis rate.
  • LP-284 is aimed at relapsed or refractory non-Hodgkin’s lymphomas, particularly mantle cell lymphoma and HGBL, within a market sized at $3.5 to $4 billion globally.
  • CNS cancers addressed by Starlight Therapeutics further expand Lantern’s reach, representing an estimated $5 billion annual global opportunity, including both adult and pediatric cancers.

Leadership Team

Panna Sharma, President, Chief Executive Officer, and Director, leads Lantern Pharma with a deep background in oncology-focused biotechnology and artificial intelligence. He is responsible for Lantern’s strategic vision and has driven the growth of its AI-powered drug development platform. Prior to joining Lantern in 2018, he served as President and CEO of Cancer Genetics Inc. (NASDAQ: CGIX), where he raised over $100 million and expanded the company from 25 to over 250 employees across multiple continents. Earlier, he founded TSG Partners and played a key role in the IPO of iXL, a digital strategy firm.

David R. Margrave, Chief Financial Officer and Secretary, has served in executive roles in life sciences for over two decades. Before joining Lantern, he held leadership positions at BioNumerik Pharmaceuticals, including President and Chief Administrative Officer. He has also been a strategic consultant to multiple biotech firms and served as Senior Legal Advisor at MedCare Investment Corporation. Mr. Margrave holds a dual degree in Economics and Petroleum Engineering from Stanford University and a J.D. from The University of Texas School of Law.

Kishor G. Bhatia, Ph.D., Chief Scientific Officer, has more than 40 years of experience in cancer biology, including leadership at the National Cancer Institute where he served as Director of the AIDS Malignancy Program and held key roles in cancer treatment and diagnosis. He has also worked as an Adjunct Investigator and consultant to biotech firms such as Reprocell and Cancer Genetics. Dr. Bhatia earned his Ph.D. in Biochemistry from the University of Mumbai and completed postdoctoral research at Johns Hopkins University. He is a Fellow of the Royal College of Pathology in the UK.

Investment Considerations
  • Lantern Pharma’s AI-driven RADR® platform integrates over 200 billion oncology-specific data points and underpins every stage of its precision oncology pipeline.
  • The company has three lead drug candidates in clinical development, targeting major oncology markets including NSCLC, TNBC, and NHL.
  • Starlight Therapeutics extends Lantern’s footprint into brain and CNS cancers, including pediatric indications supported by orphan and rare disease designations.
  • Lantern has received multiple FDA designations including Fast Track, Orphan Drug, and Rare Pediatric Disease status across its portfolio, enhancing regulatory pathways.
  • With approximately $19.7 million in cash and equivalents, the company is funded through at least mid-2026 to support pipeline advancement and platform development.

Lantern Pharma Inc. (NASDAQ: LTRN), closed Friday's trading session at $4.77, up 7.4324%, on 253,332 volume. The average volume for the last 3 months is 471,531 and the stock's 52-week low/high is $2.55/$6.118.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.